These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1329295

  • 1. The genetic basis of malignant hyperthermia.
    MacLennan DH.
    Trends Pharmacol Sci; 1992 Aug; 13(8):330-4. PubMed ID: 1329295
    [Abstract] [Full Text] [Related]

  • 2. Malignant hyperthermia.
    MacLennan DH, Phillips MS.
    Science; 1992 May 08; 256(5058):789-94. PubMed ID: 1589759
    [Abstract] [Full Text] [Related]

  • 3. The genetic basis of malignant hyperthermia.
    Moochhala SM, Tan WT, Lee TL.
    Ann Acad Med Singap; 1994 Jul 08; 23(4):475-8. PubMed ID: 7979121
    [Abstract] [Full Text] [Related]

  • 4. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.
    Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O'Brien PJ, MacLennan DH.
    Science; 1991 Jul 26; 253(5018):448-51. PubMed ID: 1862346
    [Abstract] [Full Text] [Related]

  • 5. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
    Otsu K, Nishida K, Kimura Y, Kuzuya T, Hori M, Kamada T, Tada M.
    J Biol Chem; 1994 Apr 01; 269(13):9413-5. PubMed ID: 7511586
    [Abstract] [Full Text] [Related]

  • 6. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.
    MacLennan DH, Otsu K, Fujii J, Zorzato F, Phillips MS, O'Brien PJ, Archibald AL, Britt BA, Gillard EF, Worton RG.
    Symp Soc Exp Biol; 1992 Apr 01; 46():189-201. PubMed ID: 1341035
    [Abstract] [Full Text] [Related]

  • 7. Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor.
    Mickelson JR, Knudson CM, Kennedy CF, Yang DI, Litterer LA, Rempel WE, Campbell KP, Louis CF.
    FEBS Lett; 1992 Apr 13; 301(1):49-52. PubMed ID: 1333412
    [Abstract] [Full Text] [Related]

  • 8. Genomic organization and analysis of the 5' end of the porcine ryanodine receptor gene (ryr1).
    Brenig B, Brem G.
    FEBS Lett; 1992 Feb 24; 298(2-3):277-9. PubMed ID: 1312025
    [Abstract] [Full Text] [Related]

  • 9. Ca2+ release channels of pigs heterozygous for malignant hyperthermia.
    Shomer NH, Mickelson JR, Louis CF.
    Muscle Nerve; 1995 Oct 24; 18(10):1167-76. PubMed ID: 7659111
    [Abstract] [Full Text] [Related]

  • 10. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.
    Mickelson JR, Litterer LA, Jacobson BA, Louis CF.
    Arch Biochem Biophys; 1990 Apr 24; 278(1):251-7. PubMed ID: 2321964
    [Abstract] [Full Text] [Related]

  • 11. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.
    Otsu K, Khanna VK, Archibald AL, MacLennan DH.
    Genomics; 1991 Nov 24; 11(3):744-50. PubMed ID: 1774073
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia.
    Gillard EF, Otsu K, Fujii J, Duff C, de Leon S, Khanna VK, Britt BA, Worton RG, MacLennan DH.
    Genomics; 1992 Aug 24; 13(4):1247-54. PubMed ID: 1354642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
    Du GG, Oyamada H, Khanna VK, MacLennan DH.
    Biochem J; 2001 Nov 15; 360(Pt 1):97-105. PubMed ID: 11695996
    [Abstract] [Full Text] [Related]

  • 15. A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia.
    Hogan K, Couch F, Powers PA, Gregg RG.
    Anesth Analg; 1992 Sep 15; 75(3):441-8. PubMed ID: 1510267
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of the calcium release channel of skeletal muscle sarcoplasmic reticulum in malignant hyperthermia.
    MacLennan DH, Chen SR.
    Ann N Y Acad Sci; 1993 Dec 20; 707():294-304. PubMed ID: 9137560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR, Owen VJ, Junankar PR, Taske NL, Dulhunty AF, Lamb GD.
    Biophys J; 1997 Oct 20; 73(4):1913-24. PubMed ID: 9336187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.